The Genome Engineering track will run along side Personalized Medicine and its Impact in the Clinic in the Convention Centre adjacent to the BIOTECHNICA/LABVOLUTION exhibition. Each track runs for two days and is broken down into four sessions. Delegates have the option to attend all tracks, single tracks, single days of a single track, or single sessions from 7-8 October 2015. In addition, all Genome Engineering and Personalized Medicine and its Impact in the Clinic delegates will also receive free access to the BIOTECHNICA/LABVOLUTION exhibition and the ELA Advances in LabAutomation and Robotics conference.
With over 600 exhibitors and 12,000 visitors expected to attend BIOTECHNICA/LABVOLUTION, this will be a must attend meeting for all biotech researchers, developers and manufacturers. An ideal environment for facilitating talks between pharma, biotech, academic & institutional research, solution providers and industry stakeholders. At Genome Engineering emerging and established genome editing technologies, their discovery, development and application in key organisms will be discussed. Most notably, CRISPR/Cas9 and its therapeutic potential, but also including more specialised genome engineering tools and their future industrial applications.